Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemoradiotherapy for gastrointestinal cancers.

Tyvin A Rich1, Christopher Crane, Joshua D Lawson

  • 1Department of Radiation Oncology, University of Virginia, PO Box 800383, Charlottesville, VA 22908, USA. tar4d@virginia.edu

Current Oncology Reports
|April 26, 2005
PubMed
Summary

New targeted radiosensitizing agents combined with chemotherapy and radiotherapy show promise for improved gastrointestinal cancer outcomes. These agents offer convenient oral dosing and tumor-specific activation, enhancing treatment efficacy and patient convenience.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-specific fine-tuning of a self-distilled transformer model for normal tissue segmentation in abdominal magnetic resonance guided adaptive radiotherapy.

Physics and imaging in radiation oncology·2026
Same author

Sensitivity of metastatic mucinous tailgut cyst adenocarcinoma to gemcitabine and radiation: a case report.

Frontiers in oncology·2026
Same author

A survey of regulatory recommendations for waivers of <i>in vivo</i> bioequivalence studies of generic products for certain dosage forms by participating regulators and organisations of the International Pharmaceutical Regulators Programme. Part 2.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques·2025
Same author

The additive value of morphologic grouping in assessing treatment response to ablative radiation therapy in liver metastases.

Abdominal radiology (New York)·2025
Same author

Organ Preservation in Rectal Cancer: Fear of Risks Versus the Risks of Fear.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Voxel-Based Dosimetry Predicts Local Tumor Progression Post 90 Y Radiation Segmentectomy of Colorectal Liver Metastases.

Clinical nuclear medicine·2025

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Gastrointestinal cancers often require combined chemotherapy and radiotherapy.
  • Traditional treatments face challenges with toxicity and administration methods.

Purpose of the Study:

  • To review novel radiosensitizing agents for gastrointestinal cancers.
  • To highlight the advantages of targeted systemic agents.

Main Methods:

  • Discussion of new classes of radiosensitizing agents.
  • Analysis of molecular activation mechanisms in tumors versus normal tissues.

Main Results:

  • Improved outcomes observed with new radiosensitizing agents.
  • Agents demonstrate favorable toxicity profiles.
  • Oral bioavailability and convenient dosing schedules enhance clinical utility.

Related Experiment Videos

Conclusions:

  • Targeted radiosensitizing agents represent a promising advancement in gastrointestinal cancer treatment.
  • Tumor-specific molecular activation and improved patient convenience are key benefits.